serine has been researched along with s-nitroso-n-acetylpenicillamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raiteri, M; Vallebuona, F | 1 |
Hatano, N; Ihara, H; Kambe, T; Kume, K; Miyamoto, Y; Song, T; Sugimoto, K; Tokuda, M; Watanabe, Y; Yamaguchi, F; Yamamoto, H | 1 |
Bradley, EA; Clark, MG; Eringa, EC; Korstjens, I; Musters, R; Rattigan, S; Sipkema, P; Stehouwer, CD; van Nieuw Amerongen, GP | 1 |
3 other study(ies) available for serine and s-nitroso-n-acetylpenicillamine
Article | Year |
---|---|
Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis.
Topics: Aging; Amino Acid Oxidoreductases; Animals; Behavior, Animal; Cerebellum; Cyclic GMP; Extracellular Space; Guanylate Cyclase; Hippocampus; Male; Microdialysis; N-Methylaspartate; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred WKY; Receptors, N-Methyl-D-Aspartate; S-Nitroso-N-Acetylpenicillamine; Serine; Vasodilator Agents | 1995 |
Nitric oxide-mediated modulation of calcium/calmodulin-dependent protein kinase II.
Topics: Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Cysteine; Enzyme Activation; Hippocampus; Hydrazines; Indazoles; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Protein Kinase Inhibitors; Rats; S-Nitroso-N-Acetylpenicillamine; Serine; Sulfonamides; Thyrotropin-Releasing Hormone | 2008 |
Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Arteries; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Hindlimb; Infusions, Intravenous; Microcirculation; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Nitroarginine; Phosphorylation; Pyrazoles; Pyrimidines; Rats; Regional Blood Flow; Ribonucleotides; S-Nitroso-N-Acetylpenicillamine; Serine; Threonine; Time Factors; Vascular Resistance; Vasodilation; Vasodilator Agents | 2010 |